characteristics.text: SAMN12786817
characteristics.characteristic: External Id
characteristics.text: Tianjin Medical Universuty
characteristics.characteristic: INSDC center name
characteristics.text: 2022-09-19T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2022-09-19T01:16:19.623Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS5407399
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS5407399
characteristics.characteristic: SRA accession
characteristics.text: CAL-62
characteristics.characteristic: cell line
characteristics.text: representative anaplastic thyroid carcinoma cell line
characteristics.characteristic: cell type
characteristics.text: pSer2 Pol II (Cell Signaling Technology, Cat. No.13499)
characteristics.characteristic: chip antibody
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: CAL-62_400 nM THZ531
characteristics.characteristic: source_name
characteristics.text: 400 pSer2 Pol II ChIP
characteristics.characteristic: title
characteristics.text: treated with 400 nM THZ531 for 6h
characteristics.characteristic: treatment